{
    "clinical_study": {
        "@rank": "9995", 
        "arm_group": [
            {
                "arm_group_label": "Outpatient", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Inpatient", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Patients presenting to the emergency room with upper gastrointestinal bleeding and a Glasgow\n      Blatchford score of zero will be randomly assigned to further care in the inpatient vs.\n      outpatient setting. The hypothesis of this study is that patients who are managed as\n      outpatients will require interventions at a rate not higher than those managed as inpatients\n      and will have lower direct healthcare costs."
        }, 
        "brief_title": "Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.", 
        "completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Upper Gastrointestinal Bleeding", 
        "condition_browse": {
            "mesh_term": [
                "Gastrointestinal Hemorrhage", 
                "Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Blood Urea Nitrogen < 18.2 mg/dl\n\n          2. Hemoglobin \u2265 13.0 g/dl for men and \u2265 12.0 g/dl for women\n\n          3. Systolic blood pressure \u2265 110 mm Hg\n\n          4. Heart rate < 100 beats/min\n\n        Exclusion Criteria:\n\n          1. Inability to obtain informed consent\n\n          2. Pregnancy\n\n          3. History of liver disease\n\n          4. History of heart failure\n\n          5. Syncope that is temporally related to ongoing bleeding\n\n          6. Melena\n\n          7. Contraindication to proton pump inhibitor use\n\n          8. Other conditions that necessitate inpatient evaluation.\n\n          9. Inpatients with new onset of GI bleeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "242", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02005705", 
            "org_study_id": "HIC 1307012373"
        }, 
        "intervention": [
            {
                "arm_group_label": "Outpatient", 
                "description": "Labs will be obtained within 2-3 days of discharge from ED\nClinic visit will be scheduled within 3 days of discharge from ED\nEGD will be scheduled within 7 days of discharge from ED\nPhone follow-up at day 7 and 30", 
                "intervention_name": "Outpatient Management of Low-risk Patients", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Inpatient", 
                "description": "Labs will be obtained on day of discharge or day 2-3\nEGD will be performed in the hospital\nPhone follow-up at day 7 and 30", 
                "intervention_name": "Inpatient Management of Low-risk Patients", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06510"
                }, 
                "name": "Yale New Haven Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.", 
        "overall_contact": {
            "email": "loren.laine@yale.edu", 
            "last_name": "Loren Laine, MD", 
            "phone": "203-937-3462"
        }, 
        "overall_official": {
            "affiliation": "Yale University, Section of Digestive Disease", 
            "last_name": "Loren Laine, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The number of patients requiring intervention for UGIB (endoscopic therapy, blood transfusion, surgery, interventional radiology)", 
            "safety_issue": "Yes", 
            "time_frame": "Within 7 days of the index presentation to the emergency room"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02005705"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "Loren Laine", 
            "investigator_title": "Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Yale University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}